Chartis’ analysis of LSEG Risk Intelligence is included in the report Watchlist and Adverse Media Monitoring Solutions, 2024: Market Update and Vendor Landscape, published in May 2024. Chartis has named LSEG Risk Intelligence as a category leader in the 2024 RiskTech Quadrants for Name and Transaction Screening Solutions and Adverse Media Monitoring Solutions.
The company’s platform leverages the extensive World-Check database against an advanced analytics engine, to screen and monitor customers efficiently while prioritizing scalability, speed and real-time monitoring, data management and the integrity of operations in an increasingly complex regulatory environment. LSEG Risk Intelligence’s deep expertise and support for sanctions and adverse media monitoring requirements enable the solution to provide breadth across risk types and client use cases, with an ability to address a broad array of customers in a rapidly evolving industry landscape.
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe
You are currently unable to print this content. Please contact info@chartis-research.com to find out more.
You are currently unable to copy this content. Please contact info@chartis-research.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@chartis-research.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@chartis-research.com